NEW YORK (GenomeWeb) – Veracyte said today that Medicare contractor Palmetto GBA has confirmed its local coverage determination for the Percepta Bronchial Genomic Classifier, a molecular test that identifies and screens patients with lung nodules who are at low risk of cancer following an inconclusive bronchoscopy.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Berkeley researchers have engineered yeast to make the molecule behind the hoppy taste of beer, Quartz reports.

King's College London researchers examine the influence of school type and genetics on academic achievement.

FiveThirtyEight writes that most who take a direct-to-consumer BRCA1/2 genetic test won't learn much from it.

In Science this week: early life experience influence somatic variation in the genome, and more.